This inventor holds 7 USPTO granted patents and 15 published patent applications and 2 EPO patents. Top assignees: Astellas Pharma Gmbh, Hitachi Astemo Ltd., Kotobuki Pharmaceutical Co Ltd. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 424 
2 out of 1,501 
2 out of 27 Years Active: 2024-2026
Title: Osamu Ikeda: Innovator in Cancer Treatment
Introduction
Osamu Ikeda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 7 patents, his work focuses on innovative solutions that enhance the effectiveness of cancer therapies.
Latest Patents
Ikeda's latest patents include a pyridazinyl-thiazolecarboxamide compound, which serves as an active ingredient in pharmaceutical compositions aimed at treating cancer. This compound is particularly useful for cancers related to the activation of immune cells or those resistant to anti-PD-1 antibody/anti-PD-L1 antibody therapy. The research conducted by Ikeda and his team has demonstrated that this compound exhibits a DGK ξ (DGKzeta) inhibitory effect, making it a promising therapeutic agent.
Another notable patent is the heteroaryl carboxamide compound, which also functions as an active ingredient in cancer treatment. Similar to the pyridazinyl-thiazolecarboxamide compound, this heteroaryl carboxamide has shown effectiveness against cancers that are resistant to conventional therapies. The findings from Ikeda's studies confirm its potential as a therapeutic agent in the fight against cancer.
Career Highlights
Throughout his career, Osamu Ikeda has worked with reputable companies such as Astellas Pharma GmbH and Kotobuki Pharmaceutical Co. Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.
Collaborations
Ikeda has collaborated with notable colleagues, including Hideyuki Watanabe and Yohei Seki. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Osamu Ikeda's innovative work in the field of cancer treatment exemplifies the impact of dedicated research and collaboration. His contributions through his patents are paving the way for new therapeutic options in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile